Your session is about to expire
← Back to Search
Exercise + Psychotherapy for Opioid Use Disorder (EXPO-R33 Trial)
N/A
Recruiting
Led By Nora L. Nock, PhD
Research Sponsored by Case Western Reserve University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to intervention program completion, an average of 8 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will explore if "assisted" rate cycling, voluntary rate cycling and psychotherapy can help adults with opioid use disorder with cravings, depression, anxiety and sleep.
Who is the study for?
Adults aged 18-65 with an Opioid Use Disorder or Poly-substance Drug Use including opioids, enrolled in a residential drug treatment program. Participants must have chronic non-cancer pain and be medically cleared to exercise by the treatment center's staff.
What is being tested?
The trial is testing how 'assisted' rate cycling, voluntary rate cycling, and psychotherapy for pain (I-STOP) affect cravings in opioid users. It also looks at their impact on depression, anxiety, and sleep as secondary outcomes.
What are the potential side effects?
While specific side effects are not listed for this study, exercise may cause muscle soreness or injury if not done correctly. Psychotherapy generally has no direct physical side effects but can sometimes bring up uncomfortable emotions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to intervention program completion, an average of 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to intervention program completion, an average of 8 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Drug cravings
Secondary study objectives
Anxiety
Depression
Drug Cravings using Questionnaire
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
6Treatment groups
Experimental Treatment
Active Control
Group I: Voluntary Exercise and No I-STOPExperimental Treatment1 Intervention
Participants randomized to "Voluntary Exercise" will exercise on a standard stationary bike where they will pedal at their voluntary rates. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group II: Voluntary Exercise and I-STOPExperimental Treatment2 Interventions
Participants randomized to "Voluntary Exercise" will exercise on a standard stationary bike where they will pedal at their voluntary rates. Participants who are randomized to receive I-STOP will receive the "Self-regulation Treatment for Opioid addiction and Pain" (STOP) program modified for inpatients/residential drug treatment (I-STOP).
Group III: No Exercise and I-STOPExperimental Treatment1 Intervention
Participants randomized to receive "No Exercise" will not receive structured "assisted" or voluntary rate cycling exercise. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group IV: Assisted Exercise and No I-STOPExperimental Treatment1 Intervention
Participants randomized to "Assisted Exercise" will exercise on a special bike that assists them to pedal faster than they do voluntarily on their own ("assisted" exercise bike). Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group V: Assisted Exercise and I-STOPExperimental Treatment2 Interventions
Participants randomized to "Assisted Exercise" will exercise on a special bike that assists them to pedal faster than they do voluntarily on their own ("assisted" exercise bike). Participants who are randomized to receive I-STOP will receive the "Self-regulation Treatment for Opioid addiction and Pain" (STOP) program modified for inpatients/residential drug treatment (I-STOP).
Group VI: No Exercise and No I-STOPActive Control1 Intervention
Participants randomized to receive "No Exercise" will not receive structured "assisted" or voluntary rate cycling exercise. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Find a Location
Who is running the clinical trial?
Case Western Reserve UniversityLead Sponsor
309 Previous Clinical Trials
250,965 Total Patients Enrolled
University of Colorado, DenverOTHER
1,806 Previous Clinical Trials
2,822,679 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
858 Previous Clinical Trials
672,120 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 65 years old.I am currently in a drug treatment program at a partner center.I experience chronic pain not related to cancer.You must be enrolled in a residential/inpatient drug rehabilitation program at an associated facility.You have been diagnosed with either an Opioid Use Disorder or Poly-substance Drug Use that includes opioids.You must receive authorization from the Medical Director, physician, clinical staff or PCP to participate in the study.I experience chronic pain not related to cancer.I am between 18 and 65 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Voluntary Exercise and No I-STOP
- Group 2: No Exercise and I-STOP
- Group 3: Assisted Exercise and I-STOP
- Group 4: Voluntary Exercise and I-STOP
- Group 5: Assisted Exercise and No I-STOP
- Group 6: No Exercise and No I-STOP
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT05688410 — N/A
Share this study with friends
Copy Link
Messenger